Journal
BRAIN RESEARCH
Volume 1366, Issue -, Pages 27-37Publisher
ELSEVIER
DOI: 10.1016/j.brainres.2010.10.032
Keywords
Glioma; beta-catenin; EGFR; Signaling pathway
Categories
Funding
- National Key Project of Science and Technology Supporting Programs of China [2007BAI05B08]
- China National Natural Scientific Fund [30772238, 30971136]
- Program for New Century Excellent Talents in University [NCET-07-0615]
- Tianjin Science and Technology Committee [09JCZDJC17600]
Ask authors/readers for more resources
Malignant gliomas are the most common type of intrinsic central nervous system (CNS) tumors with high mortality and morbidity. beta-catenin is overexpressed in human glioblastoma and knockdown of beta-catenin inhibits glioblastoma cell proliferation and invasive ability, and induces apoptotic cell death. Furthermore, treating the nude mice carrying established subcutaneous LN229 gliomas with siRNA targeting beta-catenin intratumorally also delayed the tumor growth. However, the mechanisms of down-regulation of beta-catenin that represses glioblastoma malignancy behavior remain to be elucidated. We utilized text-mining of MEDLINE abstracts with natural language processing to establish the beta-catenin biologic association network, and identified several interactions of this network with the EGFR pathway. In both in vitro and in vivo studies, our results confirmed down-regulation of beta-catenin induced reduced expression of EGFR, STAT3 and AKT1 mRNA and protein, besides, the level of phosphorylated Akt also decreased. A similar reduction in expression of CyclinD1, MMP2 and MMP9, downstream genes of the EGFR pathway, was observed. These results suggest that the Wnt/beta-catenin pathway regulates glioma cell proliferation and invasion, in part via the EGFR pathway. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available